What is a good HbA1c by age?

A good HbA1c for most adults is below 5.7%, but optimal ranges vary by age: younger adults should aim for 4.5-5.6%, while older adults may have slightly higher targets of 5.0-7.0% depending on health status. Individual targets should be personalized based on overall health, diabetes risk, and life expectancy.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding HbA1c and Why It Matters

Hemoglobin A1c, commonly known as HbA1c or A1c, is a blood test that provides a snapshot of your average blood sugar levels over the past 2-3 months. Unlike a single glucose reading that captures a moment in time, HbA1c reflects how well your body has been managing blood sugar over an extended period. This makes it one of the most valuable tools for assessing metabolic health and diabetes risk.

The test works by measuring the percentage of hemoglobin proteins in your red blood cells that have glucose attached to them. When blood sugar levels are consistently elevated, more glucose binds to hemoglobin, resulting in a higher HbA1c percentage. Since red blood cells typically live for about 120 days, the test effectively shows your blood sugar patterns over approximately three months.

Understanding your HbA1c is crucial because chronically elevated blood sugar can damage blood vessels, nerves, and organs throughout your body. Even in people without diabetes, higher HbA1c levels within the "normal" range are associated with increased risks of heart disease, stroke, kidney problems, and cognitive decline. Regular monitoring helps you catch concerning trends early and take action to optimize your metabolic health.

HbA1c Target Ranges by Age and Health Status

Age GroupWithout DiabetesWith Diabetes (Healthy)With Diabetes (Complex Health)
Children (<18)Children (<18)4.0-5.6%<7.0%7.0-7.5%
Young Adults (18-39)Young Adults (18-39)4.5-5.6%<6.5-7.0%7.0-7.5%
Middle-Aged (40-64)Middle-Aged (40-64)<5.7%<7.0%7.0-7.5%
Older Adults (65+)Older Adults (65+)<5.7%<7.0-7.5%7.5-8.5%

Targets should be individualized based on overall health, hypoglycemia risk, and life expectancy. Consult with healthcare providers for personalized goals.

HbA1c Ranges for Different Age Groups

Children and Adolescents (Under 18)

For children and teenagers without diabetes, a normal HbA1c typically falls between 4.0% and 5.6%. The American Diabetes Association recommends that children with Type 1 diabetes maintain an HbA1c below 7.0%, though individual targets may vary based on the child's ability to recognize hypoglycemia symptoms and other factors. During puberty, hormonal changes can make blood sugar management more challenging, sometimes requiring adjusted targets.

It's important to note that very young children, especially those under 6 years old, may have slightly higher targets if they cannot reliably communicate symptoms of low blood sugar. The goal is to balance good glycemic control with safety, avoiding dangerous hypoglycemic episodes that could affect brain development.

Young Adults (18-39 years)

Young adults should aim for an HbA1c between 4.5% and 5.6% for optimal health. This age group typically has the best capacity for tight blood sugar control and can benefit most from maintaining excellent metabolic health early in life. Research shows that keeping HbA1c in the lower end of the normal range during young adulthood can significantly reduce the risk of developing diabetes and cardiovascular disease later in life.

For young adults with diabetes, the target is generally below 7.0%, though many can safely achieve levels closer to 6.5% or even lower with proper management. The key is finding a balance that maintains good control without excessive hypoglycemia risk.

Middle-Aged Adults (40-64 years)

During middle age, maintaining an HbA1c below 5.7% remains ideal for those without diabetes. However, this is also when many people begin to see their levels creep upward due to factors like decreased physical activity, weight gain, and age-related insulin resistance. An HbA1c between 5.7% and 6.4% indicates prediabetes, signaling that intervention is needed to prevent progression to Type 2 diabetes.

For middle-aged adults with diabetes, targets may range from below 7.0% to 7.5%, depending on overall health status, diabetes duration, and presence of complications. Those who are otherwise healthy and have a longer life expectancy should aim for tighter control, while those with multiple health conditions may have slightly relaxed targets.

Older Adults (65+ years)

HbA1c targets for older adults require more individualization than any other age group. For healthy, active seniors with good cognitive function and few chronic conditions, maintaining an HbA1c below 7.0% or even in the normal range (below 5.7%) can be appropriate. However, for frail elderly individuals or those with limited life expectancy, targets may be relaxed to 7.5-8.5% to avoid the risks associated with hypoglycemia.

The key consideration for older adults is that the benefits of tight glycemic control may take years to materialize, while the risks of hypoglycemia are immediate. Low blood sugar episodes can lead to falls, confusion, and cardiovascular events, which can be particularly dangerous in this age group. Healthcare providers typically consider factors like cognitive function, physical capabilities, social support, and overall health status when setting individualized targets.

Factors That Influence Optimal HbA1c Targets

While age provides a general framework for HbA1c targets, several other factors play crucial roles in determining what's optimal for each individual. Understanding these factors helps explain why two people of the same age might have different recommended targets.

  • Overall health status and presence of other chronic conditions
  • History of hypoglycemia and ability to recognize low blood sugar symptoms
  • Life expectancy and long-term health goals
  • Access to healthcare and diabetes management resources
  • Cognitive function and ability to manage complex treatment regimens
  • Presence of diabetes complications like retinopathy or neuropathy
  • Medications that may affect blood sugar levels
  • Lifestyle factors including diet, exercise habits, and stress levels

For example, someone with a history of severe hypoglycemia might have a slightly higher HbA1c target to reduce risk, while an active individual with no complications might safely aim for tighter control. The presence of conditions like heart disease or kidney problems can also influence targets, as can medications that affect blood sugar or increase hypoglycemia risk.

How to Test and Monitor Your HbA1c

Regular HbA1c testing is essential for understanding your metabolic health trajectory. For people without diabetes or prediabetes, testing once a year is typically sufficient. However, if you have risk factors like obesity, family history of diabetes, or metabolic syndrome, more frequent testing every 6 months may be beneficial. Those with prediabetes should test every 3-6 months to monitor whether lifestyle interventions are working.

Traditional HbA1c testing requires a blood draw at a laboratory or doctor's office. However, modern at-home testing options now make it convenient to monitor your levels without scheduling clinic visits. These tests use a small blood sample from a finger prick and provide laboratory-quality results within days. Regular monitoring allows you to see how lifestyle changes affect your long-term blood sugar control and catch concerning trends early.

It's important to understand that certain conditions can affect HbA1c accuracy. Anemia, recent blood loss, pregnancy, and certain hemoglobin variants can cause falsely high or low readings. If your HbA1c results don't match your daily glucose readings or symptoms, discuss alternative testing methods with your healthcare provider, such as fructosamine or glycated albumin tests.

Strategies to Improve Your HbA1c at Any Age

Dietary Modifications

The most impactful way to improve HbA1c is through dietary changes. Focus on reducing refined carbohydrates and added sugars while increasing fiber-rich whole foods. The Mediterranean diet pattern, which emphasizes vegetables, legumes, whole grains, fish, and healthy fats, has been shown to significantly improve HbA1c levels. Consider working with a registered dietitian to create a personalized meal plan that fits your preferences and lifestyle.

  • Choose complex carbohydrates over simple sugars
  • Include protein with every meal to slow glucose absorption
  • Eat plenty of non-starchy vegetables
  • Limit processed foods and sugary beverages
  • Practice portion control, especially with carbohydrate-rich foods
  • Consider the timing of meals and avoid late-night eating

Physical Activity

Regular exercise is one of the most effective ways to lower HbA1c naturally. Both aerobic exercise and resistance training improve insulin sensitivity and help muscles use glucose more efficiently. Aim for at least 150 minutes of moderate-intensity exercise per week, spread across multiple days. Even simple activities like brisk walking after meals can significantly impact blood sugar control.

The benefits of exercise on HbA1c are both immediate and long-lasting. A single exercise session can improve insulin sensitivity for up to 48 hours, while regular training creates adaptations that enhance your body's overall glucose management. High-intensity interval training (HIIT) has shown particular promise for improving HbA1c in shorter workout durations.

Stress Management and Sleep

Chronic stress and poor sleep quality can significantly elevate HbA1c levels through hormonal mechanisms. Stress hormones like cortisol directly raise blood sugar, while sleep deprivation impairs insulin sensitivity. Prioritize getting 7-9 hours of quality sleep nightly and develop stress management techniques such as meditation, deep breathing exercises, or yoga. Even modest improvements in sleep and stress can translate to meaningful HbA1c reductions.

When to Seek Medical Guidance

While lifestyle modifications can significantly improve HbA1c, certain situations warrant professional medical evaluation. Seek guidance from a healthcare provider if your HbA1c is above 5.7%, indicating prediabetes, or if you're experiencing symptoms like excessive thirst, frequent urination, unexplained weight loss, or persistent fatigue. These could signal developing diabetes or other metabolic issues requiring intervention.

Additionally, if your HbA1c levels aren't improving despite consistent lifestyle efforts, medical evaluation can identify underlying causes such as hormonal imbalances, medication effects, or undiagnosed conditions. Your provider might recommend additional testing, medication adjustments, or referral to specialists like endocrinologists or certified diabetes educators. Remember that achieving optimal HbA1c is a journey, and professional support can make the path more successful and sustainable.

The Bottom Line on Age-Appropriate HbA1c Levels

While general guidelines suggest that an HbA1c below 5.7% is normal for adults of all ages, the optimal target for any individual depends on multiple factors beyond just age. Younger adults generally benefit from maintaining the lowest safe HbA1c levels to prevent long-term complications, while older adults may have more flexible targets based on their overall health status and life circumstances.

The key is to work with your healthcare team to establish a personalized target that balances the benefits of good glycemic control with your individual risk factors and quality of life considerations. Regular monitoring, whether through traditional lab tests or convenient at-home options, empowers you to track your progress and make informed decisions about your metabolic health. By understanding what constitutes a good HbA1c for your age and circumstances, you can take proactive steps to optimize your blood sugar control and reduce your risk of diabetes and its complications.

References

  1. American Diabetes Association Professional Practice Committee. (2024). Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024. Diabetes Care, 47(Supplement_1), S111-S125.[Link][DOI]
  2. ElSayed, N. A., Aleppo, G., Aroda, V. R., et al. (2023). Older Adults: Standards of Care in Diabetes-2023. Diabetes Care, 46(Supplement_1), S216-S229.[Link][DOI]
  3. Selvin, E., Steffes, M. W., Zhu, H., et al. (2010). Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. New England Journal of Medicine, 362(9), 800-811.[Link][PubMed][DOI]
  4. Sherwani, S. I., Khan, H. A., Ekhzaimy, A., Masood, A., & Sakharkar, M. K. (2016). Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker Insights, 11, 95-104.[Link][PubMed][DOI]
  5. International Diabetes Federation. (2021). IDF Clinical Practice Recommendations for Managing Type 2 Diabetes in Primary Care. Brussels, Belgium: International Diabetes Federation.[Link]
  6. Qaseem, A., Wilt, T. J., Kansagara, D., et al. (2018). Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: A guidance statement update from the American College of Physicians. Annals of Internal Medicine, 168(8), 569-576.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my HbA1c at home?

You can test your HbA1c at home with SiPhox Health's Core Health Program, which includes HbA1c testing along with other essential metabolic and cardiovascular biomarkers. This CLIA-certified program provides lab-quality results from a simple finger-prick blood sample collected at home.

What is the difference between HbA1c and regular blood glucose testing?

Regular blood glucose testing measures your blood sugar at a single moment, while HbA1c reflects your average blood sugar levels over the past 2-3 months. HbA1c provides a more comprehensive view of your overall blood sugar control and is better for assessing long-term metabolic health and diabetes risk.

Can HbA1c levels be too low?

Yes, while rare in people without diabetes, HbA1c levels below 4.0% may indicate hypoglycemia, certain types of anemia, or other medical conditions. Very low levels in people taking diabetes medications can signal excessive treatment and dangerous hypoglycemia risk. Always discuss unusually low results with your healthcare provider.

How quickly can I lower my HbA1c?

Since HbA1c reflects a 2-3 month average, significant changes typically take at least 3 months to show up in test results. However, you may start seeing improvements in as little as 4-6 weeks with consistent lifestyle changes. Most people can lower their HbA1c by 0.5-1.0% through dedicated diet and exercise modifications.

Does HbA1c increase naturally with age?

While HbA1c tends to rise slightly with age due to factors like decreased physical activity and age-related insulin resistance, this increase is not inevitable. Many older adults maintain excellent HbA1c levels through healthy lifestyle habits. The key is staying active, maintaining a healthy weight, and eating a balanced diet throughout life.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details